Assertio Holdings (ASRT) EBITDA (2019 - 2026)
Assertio Holdings' (ASRT) quarterly EBITDA came in at -$18.4 million in Q1 2026, down 39.88% year-on-year from -$30.6 million in Q1 2025, and down 56.35% quarter-over-quarter from -$11.7 million in Q4 2025.
Assertio Holdings (ASRT) EBITDA (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed EBITDA across 8 years of filings, most recently posting -$18.4 million for Q1 2026.
- EBITDA for Q1 2026 came in at -$18.4 million, down 39.88% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.5 million (up 19.7% YoY), and the FY2025 annual result was -$21.4 million, up 11.7% from the prior year.
- EBITDA came in at -$18.4 million for Q1 2026 at Assertio Holdings, down from -$11.7 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $88.6 million in Q4 2022 to a low of -$279.5 million in Q3 2023.
- The 5-year median for EBITDA is -$3.5 million (2024), against an average of -$16.8 million.
- Across the five-year window, EBITDA soared 1822.56% in 2022 and slumped 6797.27% in 2023, its largest moves.
- Assertio Holdings' EBITDA stood at $88.6 million in 2022, then tumbled by 164.8% to -$57.4 million in 2023, then jumped by 76.69% to -$13.4 million in 2024, then rose by 12.15% to -$11.7 million in 2025, then tumbled by 56.35% to -$18.4 million in 2026.
- The last three EBITDA figures came in at -$18.4 million (Q1 2026), -$11.7 million (Q4 2025), and $11.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | -18.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.37 Mn |
| Dec 31, 2025 | -11.75 Mn |
| Sep 30, 2025 | 11.58 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | -13.13 Mn |
| Dec 31, 2024 | -13.37 Mn |
| Sep 30, 2024 | -2.95 Mn |
| Jun 30, 2024 | -3.52 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | -57.38 Mn |
| Sep 30, 2023 | -279.54 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | -3.48 Mn |
| Dec 31, 2022 | 88.55 Mn |
| Sep 30, 2022 | 4.17 Mn |
| Jun 30, 2022 | 7.83 Mn |
| Mar 31, 2022 | 9.06 Mn |
| Dec 31, 2021 | 4.61 Mn |
| Sep 30, 2021 | 3.74 Mn |
| Jun 30, 2021 | -14.17 Mn |